Izidore Lossos
Translational Science Lead · University of Miami/Jackson Health System
Credentials: · ·
History
- Present
Lymphoma Section · University of Miami/Jackson Health System
- 1990–1991
Hadassah University Hospital
- 1987–1990
Hadassah University Hospital
Research
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Nature · 2000 · 6,794 citations
Cell · 2010 · 943 citations
Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes
New England Journal of Medicine · 2004 · First of 7 authors · 722 citations
55 papers · 19 as a fellow
47 papers
46 papers
30 papers
29 papers
- BK
26 papers
- BL
21 papers
21 papers
Grants
- 2019–2025
National Cancer Institute · R01
Contact PI · $1.8M · University of Miami School of Medicine
- 2005–2014
Significance and Function of HGAL in Lymphoma
National Cancer Institute · R01
Contact PI · $2.1M · University of Miami School of Medicine
- 2007–2012
Prognostic Models in Diffuse Large B-Cell Lymphoma
National Cancer Institute · R01
Contact PI · $1.3M · University of Miami School of Medicine
Clinical trials
- 2025–2031
Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)
Principal investigator · Recruiting · Phase 2
Izidore Lossos, MD
- 2024–2030
Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma
Principal investigator · Recruiting · Phase 2
Izidore Lossos, MD
- 2022–2029
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
Principal investigator · Recruiting · Phase 2
University of Miami
- 2015–2023
Principal investigator · Completed · Phase 2
University of Miami